Related Experiment Video
Updated: May 10, 2026

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
miR-223: infection, inflammation and cancer
M Haneklaus1, M Gerlic, L A J O'Neill
1Inflammation Research Group and Immunology Research Centre, School of Biochemistry and Immunology, Trinity College Dublin, Ireland.
MicroRNA miR-223 plays a crucial role in regulating inflammation and preventing cancer. This microRNA impacts key cellular processes, including immune responses and myeloid differentiation, offering potential therapeutic avenues.
Area of Science:
- Molecular Biology
- Immunology
- Oncology
Background:
- MicroRNA miR-223 expression is altered in various diseases, including infections, inflammatory conditions, and cancers.
- Emerging evidence suggests miR-223's involvement in modulating inflammation and preventing oncogenic transformations.
Purpose of the Study:
- To review recent studies on miR-223 function.
- To elucidate miR-223's role in inflammation, infection, and cancer development.
Main Methods:
- Literature review of studies investigating miR-223.
- Analysis of validated miR-223 targets and their impact on cellular processes.
Main Results:
- miR-223 targets key mediators of inflammation (e.g., STAT3, NF-κB) and cancer (e.g., C/EBPβ, E2F1).
- miR-223 influences hematopoietic cell differentiation, particularly granulocytes.
- miR-223 dampens inflammatory pathways like the NLRP3 inflammasome and can directly target viruses.
Conclusions:
- miR-223 is a significant modulator of inflammation, infection, and cancer.
- Its multifaceted targeting suggests a central role in maintaining cellular homeostasis and preventing disease.
Related Concept Videos
MicroRNAs
MicroRNAs
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
The Tumor Microenvironment

